Skip to content

A multi-center randomized controlled clinical trial of massage therapy for mild allergic rhinitis in children

A multi-center randomized controlled clinical trial of massage therapy for mild allergic rhinitis in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005983
Enrollment
Unknown
Registered
2022-05-08
Start date
2022-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis in children

Interventions

Control group:Loratadine syrup

Sponsors

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 14 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 6-14 years old, no gender limit;(2) Children with mild allergic rhinitis with a clear diagnosis;(3) Before the start of the research, the subjects and their legal guardians can fully know and understand the research content of this research, participate voluntarily and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1)Non-allergic rhinitis (including acute rhinitis, chronic rhinitis, atrophic rhinitis, caseous rhinitis, etc.), anatomical factors or other factors causing blockage of the nasal cavity;(2)Children with episodic respiratory diseases such as bronchial asthma; (3) Those who have used hormones, antihistamines, leukotriene receptor antagonists and other related drugs for treatment within the last month, or are participating in other clinical trials that have an impact on the research.

Design outcomes

Primary

MeasureTime frame
total symptom score;total nasal symptom score;

Secondary

MeasureTime frame
Total effective rate;Adverse events;

Countries

China

Contacts

Public ContactWang Yanguo
wygwbl@163.com13752053466

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026